miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.
about
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionInhibition of microRNA function by antimiR oligonucleotidesMicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancersSpanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeChemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastomaThe impact of cellular senescence in cancer therapy: is it true or not?Significance and therapeutic value of miRNAs in embryonal neural tumorsSmall molecule chemical probes of microRNA functionThe microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesisA p53 drug response signature identifies prognostic genes in high-risk neuroblastomaInhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsThe dichotomy of p53 regulation by noncoding RNAs.MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4.miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways.The duality of oncomiR addiction in the maintenance and treatment of cancer.The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.MicroRNAs as potential therapeutics for treating spinal cord injury.Identification of new p53 target microRNAs by bioinformatics and functional analysisMiR-1188 at the imprinted Dlk1-Dio3 domain acts as a tumor suppressor in hepatoma cells.An unexpected role for caspase-2 in neuroblastoma.Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.Genetic Variation in the 3'-Untranslated Region of NBN Gene Is Associated with Gastric Cancer Risk in a Chinese PopulationMicroRNAs in apoptosis, autophagy and necroptosisMicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.MicroRNAs and other non-coding RNAs as targets for anticancer drug development.Induction of hepatocellular carcinoma by in vivo gene targeting.MiR-125b protects against ethanol-induced apoptosis in neural crest cells and mouse embryos by targeting Bak 1 and PUMA.Molecular mechanisms of MYCN-dependent apoptosis and the MDM2-p53 pathway: an Achille's heel to be exploited for the therapy of MYCN-amplified neuroblastoma.The microcosmos of cancer.MicroRNAs in Ewing Sarcoma.Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium ProgramSpecies-specific mutual regulation of p53 and miR-138 between human, rat and mouseNon-coding RNAs in DNA damage and repair.Neuroblastoma and MYCNMicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma.Clinical applications of microRNAs.Neuroblastoma treatment in the post-genomic era.
P2860
Q21134914-6728BED8-9B2A-4078-BC59-66458D9D434CQ21198757-749A9988-77D8-41C6-81E1-3C274FD88DB6Q26745980-CD727625-B719-481B-A586-A84EE192851AQ26770333-F2FF373E-33DE-4FA7-9936-DA7518A6A890Q26800007-A8A5D642-9A35-4FBD-92D4-F324F5DE8D85Q26825221-35124FB9-7AC7-46EA-899E-0CB19F59DB02Q26827171-BF4CE7D1-4F81-432D-930D-E0E3A438AD9BQ27025357-9D805098-006B-4112-BC1E-E12B2E2F3118Q28271675-89E75384-86AF-4B59-834F-12C0B615B7F4Q28537647-C127B082-FFA5-4581-A5A5-C29DB5A15AFBQ28817295-C689A1D0-699A-487C-90FB-F08BE0E85441Q33668469-34CC92BA-0C79-4362-82B8-7019028BF6AFQ33728193-94F5278B-3C41-4E91-AF27-07446EA10D33Q33909637-EC197F61-3EC3-45E1-8AED-8BC457ED41A9Q34268565-5F197248-9241-4906-9EBC-DD203FA6AB67Q34278112-EC7D3E8C-B6DA-4EFC-ABB4-08E1B6E269DBQ34356918-DD50F40E-CA34-4163-B1DA-6385791A7070Q34466211-F43EE2EB-7AC2-4283-9DCA-94D9042CD25EQ35020885-04AB939C-F89A-437B-A7CC-7905740219DFQ35047617-DD6AC024-F5C0-4401-B7BD-D6564DFACD1EQ35390062-9D12B0CD-289A-4E46-AF0D-2FAAB0175DE3Q35679550-9C35C99B-F7FF-4A4F-A5E3-1077B7C563C1Q35735278-AB068380-C6D0-4D89-A1B4-F51785ED7D37Q35786743-56FC37CE-CC4F-41B2-9801-4E65FAFAF245Q35832148-0C9724C1-FF77-4E1A-9CF6-023E191ACD3FQ35951821-A43AFC10-BEDD-4576-81A5-4371080C9084Q35994443-15417CA9-2D77-4E1E-BA43-0A483F3C3427Q36094151-97F8791A-029A-43AD-8580-A6ED4C7120EBQ36101583-634BEF34-FC83-4CC9-B4E9-4932D6A8B46FQ36313712-0401809B-56CF-4488-A943-2B1740848AAAQ36432986-FA554E51-A461-4C7F-9988-A561171A90E9Q36722134-C7F50B9A-1A09-4139-827B-70B8F202A92FQ36889725-13742106-3532-470A-B8B3-29F10E7229AEQ36906609-3DBA3D26-80FD-49FD-8915-B224A45FDA42Q37009459-B7BA1587-2AA6-4D5C-84C1-1689297B473CQ37201479-D0BE757B-BC54-46E3-8DF7-ED44B13DDFCEQ37423734-31FCF29E-4AE0-430D-9D0A-58F4A50D9331Q37565598-7D2F3C88-D090-413C-BAC3-23FFD81DB2B0Q37567411-D67F295B-5716-4778-A570-B249D3E1F07EQ37633731-393FB291-CCC9-43BE-9E8F-777E166F7F2D
P2860
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@ast
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@en
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@nl
type
label
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@ast
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@en
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@nl
prefLabel
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@ast
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@en
miR-380-5p represses p53 to co ...... MYCN-amplified neuroblastoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
miR-380-5p represses p53 to co ...... n MYCN-amplified neuroblastoma
@en
P2093
Akira Nguyen
Albert Chetcuti
Alexander Shaw
Andrei Goga
Asha Balakrishnan
Christopher S Hackett
Christopher S Sullivan
Eric G Marcusson
Lesley J Ashton
Lionel Lim
P2860
P2888
P304
P356
10.1038/NM.2227
P407
P577
2010-09-26T00:00:00Z